Licensing agreement provides a unique opportunity to develop curative therapies for multiple life-threatening fibrotic conditions.

These award-winning solutions provide scientists across a range of fields and disciplines with the ability to conduct comprehensive proteome profiling and quantitation, biomarker discovery and verification, and the full characterization of complex biotherapeutics.

First-of-its-kind technology advances the ability to detect and analyze exosomes with high sensitivity and specificity.

BMG LABTECH introduced today the new CLARIOstar® Plus, further extending its range of high-quality microplate readers.

Newest version of industry-leading lab management solution enables robust, easy-to-use, comprehensive work assignment and resource planning.

Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.

New rocking motion single-use bioreactor system to culture cell products in working volumes up to 5 L.

The highly scalable and simple ChIP workflow enables researchers to easily isolate protein-DNA complexes for downstream applications

Company has announced it has the largest global directory of cancer models on its Cancer Models Platform, which contains over 4,500 models.

MANTA has earned a high reputation for its nanoparticle characterization technology.